文献速递腹部CT

双能CT评估胃癌新辅助化疗后肿瘤退缩分级

Dual-energy CT for evaluating the tumor regression grade of gastric cancer after neoadjuvant chemotherapy.
PubMed 文献 · Eur Radiol · 2025-03-18

本回顾性研究纳入54例病理确诊胃癌患者,按肿瘤退缩分级(TRG)分为有效组21例与无效组33例,比较双能CT参数碘浓度、标准化碘浓度及能谱曲线斜率及其化疗前后变化率。结果显示静脉期标准化碘浓度变化率(%ΔNIC-v)估算TRG的AUC为0.877,高于RECIST 1.1的0.649。

要点

  • 静脉期标准化碘浓度变化率(%ΔNIC-v)与TRG相关性最强(r=-0.766)。
  • %ΔNIC-v估算TRG的AUC为0.877,高于RECIST 1.1的0.649。
  • RECIST 1.1与TRG的一致性仅为一般(Kappa=0.299)。

核心结论

  • 双能CT参数尤其是静脉期标准化碘浓度变化率(%ΔNIC-v)在评估胃癌新辅助化疗疗效方面显示出前景。

研究设计与样本

  • 回顾性研究,共纳入54例病理确诊胃癌患者,按TRG结果分为有效组(n=21)与无效组(n=33),获取双能CT参数碘浓度(IC)、标准化碘浓度(NIC)及能谱曲线斜率(λ),比较化疗前后定量参数及其变化率并绘制ROC曲线。

诊断标准与关键数值

  • 静脉期标准化碘浓度变化率(%ΔNIC-v)估算TRG的AUC为0.877(95%CI:0.772-0.957),RECIST 1.1的AUC为0.649(95%CI:0.496-0.803),两者差异有统计学意义(p<0.05);RECIST 1.1与TRG一致性Kappa值为0.299(p<0.05)。

临床应用与阅片要点

  • 双能CT定量参数可为胃癌新辅助化疗后病理反应的无创术前预测提供可靠工具。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To evaluate the clinical value of dual-energy CT (DECT) parameters in estimating tumor regression grade (TRG) of gastric cancer after neoadjuvant chemotherapy (NAC).

MATERIALS AND METHODS: In this retrospective study, the patients with pathologically confirmed gastric cancer were classified into two groups based on TRG results: the effective group and the ineffective group. DECT parameters, including iodine concentration (IC), normalized iodine concentration (NIC), and slope of the energy spectrum curve (λ), were obtained. Quantitative parameters and their change rates were compared before and after chemotherapy. The receiver operating characteristic (ROC) curves were plotted.

RESULTS: A total of 54 patients were included and divided into the effective group (n = 21) and the ineffective group (n = 33). After NAC, the change rates of parameters in the venous phase (%ΔIC-v, %ΔNIC-v, and %Δλ-v) were notably higher in the effective group were higher than in the ineffective group (all p < 0.05). The consistency between the response evaluation criteria in solid tumors version 1.1 (RECIST 1.1) and TRG was fair, with a Kappa value of 0.299 (p < 0.05). The %ΔIC-v, %ΔIC-d, %ΔNIC-v, %ΔNIC-d, and %Δλ-v exhibited moderate or strong correlations with TRG, with correlation coefficients (r) of -0.624, -0.475, -0.766, -0.516, and -0.431, respectively (all p < 0.05). %ΔNIC-v achieved a significantly greater area under the curve (AUC) compared to RECIST 1.1 (AUC, 0.877; 95% CI: 0.772-0.957; vs AUC, 0.649; 95% CI: 0.496-0.803; p < 0.05) for estimating TRG in gastric cancer.

CONCLUSION: DECT parameters, particularly %ΔNIC-v, show promise in assessing the efficacy of NAC for gastric cancer.

KEY POINTS: Question Two-dimensional morphological change is insufficient for accurately assessing the pathological TRG following NAC in gastric cancer. Findings DECT parameters show higher preoperative predictive efficacy than RECIST 1.1 for TRG in gastric cancer. Clinical relevance DECT-derived quantitative parameters offer a reliable and noninvasive tool for the preoperative prediction of pathological response in gastric cancer patients undergoing NAC.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Lin Y, Lan Y, Zheng Y, et al. Dual-energy CT for evaluating the tumor regression grade of gastric cancer after neoadjuvant chemotherapy. Eur Radiol. 2025. PMID: 40100398. doi:10.1007/s00330-025-11508-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。